US · USD
GMED
Globus Medical
- Day's range
- $75.85 – $77.66
- Day's volume
- $37.2M
- 52-week range
- $56.57 – $96.82
Follow GMED in the Fuolio
See how GMED weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountGMED in numbers
- Market cap
- $10.3B
- P/E
- 19.26
- P/B
- 2.16
- Dividend yield (12m)
- 0.00%
GMED trades at 19.26 times its earnings of the last 12 months.
GMED price history
GMED risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | -15.64% | +70.97% | +22.64% |
| Volatility (annualized) | 19.01% | 44.83% | 40.05% |
| Largest drawdown | -21.54% | -43.24% | -43.24% |
| Positive months | 6/12 | 18/36 | 32/60 |
How much did investing in GMED return?
$1,000.00 invested on 11/01/2021 would be worth $1,226.45 today.
- Value today in GMED
- $1,226.45
- Return over the period
- +22.64%
- Return per year
- +4.23%
- In the S&P 500
- $1,713.54
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
GMED fundamentals
Valuation
- P/E19.26
- P/B2.16
- EV/EBITDA11.23
- EV/EBIT16.15
- EV/Revenue3.28
- P/EBIT16.15
- P/S3.28
- P/OCF11.34
- P/FCF13.67
- Earnings yield6.19%
- PEG ratio—
- Earnings per share$3.99
- Book value per share$35.52
Debt
- Net debt—
- Net debt/EBITDA—
- Net debt/Equity—
- Debt/Equity—
- Current ratio4.62
- Quick ratio2.93
- Cash ratio1.24
Efficiency
- Gross margin68.55%
- EBITDA margin29.24%
- Operating margin20.34%
- Net margin17.03%
- Asset turnover0.57
Profitability
- ROE11.23%
- ROA9.76%
- ROIC10.88%
- Payout0.00%
Growth
- Revenue CAGR (5 years)27.65%
- Earnings CAGR (5 years)23.81%
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
What is GMED's fair price?
Two classic value formulas, with today's numbers. The current price is $76.80.
- Graham's fair price
- $56.45
- 26.49% below the price
√(22.50 × $3.99 × $35.52)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- —
- Does not apply to GMED: it paid no distributions in the last five years.
Décio Bazin only bought stocks yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years over 6%.
Graham ignores growth and debt; Bazin assumes past distributions repeat. They are references to compare, not a buy recommendation.
GMED's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | 21.96 | 110.46 | 58.71 | 39.17 | 49.15 | 63.63 | 37.87 | 27.29 |
| P/B | 2.58 | 2.72 | 1.80 | 4.03 | 4.21 | 4.32 | 4.19 | 3.60 |
| EV/EBITDA | 15.61 | 27.13 | 25.89 | 25.15 | 30.32 | 37.34 | 26.16 | 20.24 |
| Earnings per share | $3.98 | $0.75 | $0.91 | $1.90 | $1.47 | $1.02 | $1.55 | $1.59 |
| Book value per share | $33.81 | $30.37 | $29.53 | $18.41 | $17.15 | $15.09 | $14.05 | $12.02 |
| ROE | 11.76% | 2.47% | 3.07% | 10.30% | 8.57% | 6.79% | 11.07% | 13.20% |
| ROIC | 9.33% | 3.39% | 2.47% | 9.66% | 8.17% | 6.01% | 10.02% | 11.85% |
| Gross margin | 67.41% | 58.90% | 65.05% | 74.22% | 75.03% | 72.44% | 77.08% | 77.64% |
| EBITDA margin | 25.75% | 16.65% | 17.77% | 28.96% | 25.24% | 22.09% | 28.61% | 29.59% |
| Net margin | 18.30% | 4.09% | 7.83% | 18.59% | 15.57% | 12.96% | 19.76% | 21.95% |
GMED's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $2.9B | $2.5B | $1.6B | $1B | $958.1M | $789M |
| Cost of revenue | -$957.8M | -$1B | -$548.2M | -$263.7M | -$239.2M | -$217.5M |
| Gross profit | $2B | $1.5B | $1B | $759.1M | $718.9M | $571.6M |
| EBITDA | $756.7M | $419.4M | $278.7M | $296.2M | $241.8M | $174.3M |
| EBIT | $479.8M | $166M | $133.1M | $228M | $172M | $111.4M |
| Financial result | $125.3M | -$45.3M | $32.3M | $15.1M | — | — |
| Income before tax | $605.1M | $120.7M | $165.4M | $243M | $180.4M | $125.9M |
| Income tax | -$67.2M | -$17.7M | -$42.5M | -$52.9M | -$31.2M | -$23.6M |
| Net income | $537.9M | $103M | $122.9M | $190.2M | $149.2M | $102.3M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does GMED pay dividends?
GMED has no distributions on record.
About Globus Medical
- Sector
- Manufacturing
Questions about GMED
How much is GMED today?
GMED is at $76.80 (0.30% on the day), last traded on 10/06/2026.
What are the P/E and P/B of GMED?
GMED trades at a P/E of 19.26 and a P/B of 2.16.
How much did GMED return in 12 months?
GMED returned -15.64% in 12 months, with annualized volatility of 19.01% and a largest drawdown of -21.54%.